nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.0789	0.0789	CbGpPWpGaD
Tofisopam—PDE2A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.0625	0.0625	CbGpPWpGaD
Tofisopam—PDE10A—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.0598	0.0598	CbGpPWpGaD
Tofisopam—PDE10A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.0474	0.0474	CbGpPWpGaD
Tofisopam—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.0352	0.0352	CbGpPWpGaD
Tofisopam—PDE2A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.0307	0.0307	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.0292	0.0292	CbGpPWpGaD
Tofisopam—PDE3A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.0279	0.0279	CbGpPWpGaD
Tofisopam—PDE10A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.0233	0.0233	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.0221	0.0221	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.0209	0.0209	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.0196	0.0196	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.0148	0.0148	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.014	0.014	CbGpPWpGaD
Tofisopam—PDE3A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.0137	0.0137	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.013	0.013	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.0117	0.0117	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.0106	0.0106	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00888	0.00888	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00885	0.00885	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.0088	0.0088	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00873	0.00873	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00832	0.00832	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00804	0.00804	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00799	0.00799	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00764	0.00764	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0074	0.0074	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00697	0.00697	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00688	0.00688	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00677	0.00677	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00672	0.00672	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00671	0.00671	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00667	0.00667	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00646	0.00646	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0063	0.0063	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00626	0.00626	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00615	0.00615	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00609	0.00609	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00606	0.00606	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.0058	0.0058	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00579	0.00579	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00578	0.00578	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00574	0.00574	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00561	0.00561	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00528	0.00528	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00523	0.00523	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00522	0.00522	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00521	0.00521	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00513	0.00513	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00509	0.00509	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.0049	0.0049	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00476	0.00476	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00475	0.00475	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00472	0.00472	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00466	0.00466	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00439	0.00439	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00438	0.00438	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00435	0.00435	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00433	0.00433	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00407	0.00407	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00404	0.00404	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00397	0.00397	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00395	0.00395	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00395	0.00395	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00393	0.00393	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00382	0.00382	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00372	0.00372	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00369	0.00369	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00367	0.00367	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00366	0.00366	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00363	0.00363	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00361	0.00361	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0036	0.0036	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00359	0.00359	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00358	0.00358	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00357	0.00357	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00351	0.00351	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00341	0.00341	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0034	0.0034	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00331	0.00331	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00328	0.00328	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00311	0.00311	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00311	0.00311	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00309	0.00309	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00308	0.00308	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00307	0.00307	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00302	0.00302	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00301	0.00301	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.003	0.003	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00299	0.00299	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00297	0.00297	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00289	0.00289	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00283	0.00283	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00282	0.00282	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00277	0.00277	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00275	0.00275	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00275	0.00275	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00264	0.00264	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00259	0.00259	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00258	0.00258	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00256	0.00256	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00256	0.00256	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00239	0.00239	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00236	0.00236	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00233	0.00233	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00233	0.00233	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00226	0.00226	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00219	0.00219	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00217	0.00217	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00214	0.00214	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00213	0.00213	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00212	0.00212	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00211	0.00211	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00199	0.00199	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00196	0.00196	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00194	0.00194	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00193	0.00193	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00182	0.00182	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00179	0.00179	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00177	0.00177	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00167	0.00167	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00163	0.00163	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00162	0.00162	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00138	0.00138	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00133	0.00133	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.0013	0.0013	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00126	0.00126	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00124	0.00124	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00108	0.00108	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00105	0.00105	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00094	0.00094	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000902	0.000902	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000878	0.000878	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000691	0.000691	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000672	0.000672	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00057	0.00057	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000554	0.000554	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000416	0.000416	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000366	0.000366	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000338	0.000338	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	0.000254	0.000254	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	0.000217	0.000217	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	0.000167	0.000167	CbGpPWpGaD
